Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 24009802)

1.

Delirium followed by neuroleptic malignant syndrome in rehabilitation setting. Is it anger reaction before discharge?

Al Owesie RM, Robert AA.

Pan Afr Med J. 2013 May 18;15:26. doi: 10.11604/pamj.2013.15.26.2218. eCollection 2013.

2.
3.

Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics.

Hatch CD, Lund BC, Perry PJ.

Pharmacotherapy. 2001 Aug;21(8):1003-6.

PMID:
11718487
4.
5.

Atypical neuroleptic malignant syndrome caused by olanzapine.

Nielsen J, Bruhn AM.

Acta Psychiatr Scand. 2005 Sep;112(3):238-40; discussion 240.

PMID:
16095481
6.

[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].

Khaldi S, Kornreich C, Choubani Z, Gourevitch R.

Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2. Review. French.

PMID:
19081460
7.

Neuroleptic malignant syndrome in a burn patient.

Still J, Friedman B, Law E, Deppe S, Epperly N, Orlet H.

Burns. 1998 Sep;24(6):573-5.

PMID:
9776099
8.

Neuroleptic malignant syndrome and cardiac surgery. A case report.

Sirois F.

J Cardiovasc Surg (Torino). 2008 Oct;49(5):695-6.

PMID:
18670390
9.

Early recognition of neuroleptic malignant syndrome during traumatic brain injury rehabilitation.

Kadyan V, Colachis SC, Depalma MJ, Sanderson JD, Mysiw WJ.

Brain Inj. 2003 Jul;17(7):631-7.

PMID:
12775273
10.

Delirium with dystonia: a variant of neuroleptic malignant syndrome?

Dowling JJ, Patrick V.

Am J Psychiatry. 1989 Feb;146(2):276-7. No abstract available.

PMID:
2563212
11.

Neuroleptic malignant syndrome as a possible postoperative complication: a case report.

Kuhn WF, Lippmann SB.

Gen Hosp Psychiatry. 1987 May;9(3):179-81.

PMID:
2884165
12.

Neuroleptic malignant syndrome due to olanzapine.

Hall KL, Taylor WH, Ware MR.

Psychopharmacol Bull. 2001 Summer;35(3):49-54.

PMID:
12397878
13.

Clozapine, neuroleptic malignant syndrome, and pancerebellar syndrome.

Brown TM.

Psychosomatics. 1999 Nov-Dec;40(6):518-20. No abstract available.

PMID:
10581982
14.
15.

Neuroleptic malignant syndrome during haloperidol treatment in a cancer patient. A case report.

Tanaka K, Akechi T, Yamazaki M, Hayashi R, Nishiwaki Y, Uchitomi Y.

Support Care Cancer. 1998 Nov;6(6):536-8.

PMID:
9833304
16.

Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.

Eiden C, Capdevielle D, Deddouche C, Boulenger JP, Blayac JP, Peyrière H.

J Addict Med. 2011 Dec;5(4):302-3. doi: 10.1097/ADM.0b013e3182236730.

PMID:
21817917
17.

Intravenous administration of lisuride in the treatment of neuroleptic malignant syndrome.

de Mari M, Lamberti P, Simone F, Iliceto G, Federico F, Ferrari E.

Funct Neurol. 1991 Jul-Sep;6(3):285-8.

PMID:
1683852
18.

Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol.

Bellamy CJ, Kane-Gill SL, Falcione BA, Seybert AL.

J Trauma. 2009 Mar;66(3):954-8. doi: 10.1097/TA.0b013e31818e90ed. Review.

PMID:
19276778
19.

Clinical risk factors for neuroleptic malignant syndrome.

Berardi D, Dell'Atti M, Amore M, De Ronchi D, Ferrari G.

Hum Psychopharmacol. 2002 Mar;17(2):99-102.

PMID:
12404699
20.

[Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report].

Terlikowska M, Marzański M.

Psychiatr Pol. 1995 May-Jun;29(3):343-8. Polish.

PMID:
7652087
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk